---
$id: https://graph.org.ai/products/commodity/51111752
$type: Product
source: UNSPSC
code: "51111752"
title: "Menogaril"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Menogaril

**UNSPSC Code**: 51111752
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C28H31NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8JSV4O30HQ, chemically known as 2,6-epoxy-2h-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2r-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))- but generally known as menogaril, which bears US NIH Compound Identifier 51370. European Medicines Agency schedules Menogaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08742MIG. The term MENOGARIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). MENOGARIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule menogaril under HS 29419000 and SITC 54139. As of Q4 2014, MENOGARIL remains the US FDA Preferred Term for this commodity. Menogaril bears US NLM identifiers UMLS ID C0127527 and NCI Concept Code C1389. SMILES: O1C2(C(O)C(N(C)C)C(O)C1OC1C2CC(O)C2C1C(=O)C1C(C2=O)C(O)C2C(OC)CC(O)(CC2C1)C)C.

